A population-based matched cohort study of major congenital anomalies following COVID-19 vaccination and SARS-CoV-2 infection
Open Access
- 6 January 2023
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-11
Abstract
Evidence on associations between COVID-19 vaccination or SARS-CoV-2 infection and the risk of congenital anomalies is limited. Here we report a national, population-based, matched cohort study using linked electronic health records from Scotland (May 2020-April 2022) to estimate the association between COVID-19 vaccination and, separately, SARS-CoV-2 infection between six weeks pre-conception and 19 weeks and six days gestation and the risk of [1] any major congenital anomaly and [2] any non-genetic major congenital anomaly. Mothers vaccinated in this pregnancy exposure period mostly received an mRNA vaccine (73.7% Pfizer-BioNTech BNT162b2 and 7.9% Moderna mRNA-1273). Of the 6731 babies whose mothers were vaccinated in the pregnancy exposure period, 153 had any anomaly and 120 had a non-genetic anomaly. Primary analyses find no association between any vaccination and any anomaly (adjusted Odds Ratio [aOR] = 1.01, 95% Confidence Interval [CI] = 0.83-1.24) or non-genetic anomalies (aOR = 1.00, 95% CI = 0.81-1.22). Primary analyses also find no association between SARS-CoV-2 infection and any anomaly (aOR = 1.02, 95% CI = 0.66-1.60) or non-genetic anomalies (aOR = 0.94, 95% CI = 0.57-1.54). Findings are robust to sensitivity analyses. These data provide reassurance on the safety of vaccination, in particular mRNA vaccines, just before or in early pregnancy.Keywords
All Related Versions
Funding Information
- Wellcome Trust (220283/Z/20/Z, 209560/Z/17/Z)
- RCUK | Medical Research Council (MC_UU_00022/2, MC_PC_19075)
- Scottish Government Chief Scientist Office (SPHSU17) NRS Senior Clinical Fellowship
- Tommy’s Charity
This publication has 27 references indexed in Scilit:
- Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 InfectionJAMA Pediatrics, 2021
- Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant PersonsNew England Journal of Medicine, 2021
- COVID‐19 vaccine acceptance in pregnant womenInternational Journal of Gynecology & Obstetrics, 2021
- COVID-19 in Pregnancy in Scotland (COPS): protocol for an observational study using linked Scottish national dataBMJ Open, 2020
- Pregnancy Outcomes Among Women With and Without Severe Acute Respiratory Syndrome Coronavirus 2 InfectionJAMA Network Open, 2020
- Analysis of SARS-CoV-2 vertical transmission during pregnancyNature Communications, 2020
- Infant Outcomes Following Maternal Infection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): First Report From the Pregnancy Coronavirus Outcomes Registry (PRIORITY) StudyClinical Infectious Diseases, 2020
- Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysisBMJ, 2020
- Congenital anomalies: Case definition and guidelines for data collection, analysis, and presentation of immunization safety dataVaccine, 2016
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesThe Lancet, 2007